---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-22-002114"
form_type: "8-K"
ticker: "MD"
cik: "0000893949"
company_name: "Pediatrix Medical Group, Inc."
filed_at: "2022-02-25T23:59:59+00:00"
generated_at: "2026-06-27T04:28:31.643828+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "high"
source: SEC EDGAR
---

# Mednax President of Pediatrix and Obstetrix Medical Group Roger Mack Hinson to step down effective June 1, 2022

## Summary
- Dr. Hinson will transition from his role as President effective June 1, 2022.
- Termination is without 'Cause' under his Amended and Restated Employment Agreement.
- Company and Dr. Hinson intend to enter a consulting agreement for advisory services post-transition.
- No replacement for the President role has been announced.

## SEC filing metadata
- accession: 0000950170-22-002114
- form_type: 8-K
- ticker: MD
- cik: 0000893949
- company_name: Pediatrix Medical Group, Inc.
- filed_at: 2022-02-25T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/893949/000095017022002114/0000950170-22-002114-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/893949/000095017022002114/md-20220223.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-22-002114
- JSON: https://secwatch.observer/filing/0000950170-22-002114.json
- Plain text: https://secwatch.observer/filing/0000950170-22-002114.txt

## Key facts
- Executive change
  Roger Mack Hinson changed role as President of the Company’s Pediatrix and Obstetrix Medical Group at Pediatrix Medical Group, Inc..
  - Action: transitioned
  - Role: President of the Company’s Pediatrix and Obstetrix Medical Group
  source text: On February 23, 2022, Mednax, Inc., a Florida corporation (the “Company”), announced that Roger Mack Hinson, M.D., President of the Company’s Pediatrix and Obstetrix Medical Group, would transition from such position, effective as of June 1, 2022 (the “Effective Date”).
  evidence_url: https://www.sec.gov/Archives/edgar/data/893949/000095017022002114/0000950170-22-002114-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.